Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients.
Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands s.d.pouwels@umcg.nl.
Simon D
SD
Pouwels
Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Martijn C
MC
Nawijn
Dept of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Erik
E
Bathoorn
Dept of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Annelies
A
Riezebos-Brilman
Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Antoon J M
AJ
van Oosterhout
GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Huib A M
HA
Kerstjens
Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Irene H
IH
Heijink
D000368:Aged; D023181:Antimicrobial Cationic Peptides; D001424:Bacterial Infections / Q000150:complications; D040502:Calgranulin B / Q000097:blood*; D054804:Cathelicidins / Q000097:blood*; D018450:Disease Progression; D005260:Female; D005786:Gene Expression Regulation; D024243:HMGB1 Protein / Q000097:blood*; D006801:Humans; D007249:Inflammation; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000503:physiopathology*; D011788:Quality of Life; D012737:Sex Factors; D014777:Virus Diseases / Q000150:complications
D023181:Antimicrobial Cationic Peptides; D040502:Calgranulin B; D054804:Cathelicidins; D024243:HMGB1 Protein; C585491:HMGB1 protein, human